▶ 調査レポート

世界の予防用ワクチン産業調査2019-2025

• 英文タイトル:Global Preventive Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の予防用ワクチン産業調査2019-2025 / Global Preventive Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2019-2025 / QYR9NV16846資料のイメージです。• レポートコード:QYR9NV16846
• 出版社/出版日:QYResearch / 2019年11月18日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、114ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医薬品・ヘルスケア
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※本調査レポートでは、世界の予防用ワクチン市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。予防用ワクチンの種類別には、筋肉内注射、点鼻薬、皮内注射に、用途別には、病院、診療所、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・予防用ワクチンの種類別市場規模:筋肉内注射、点鼻薬、皮内注射
・予防用ワクチンの用途別市場規模:病院、診療所、その他
・予防用ワクチンの地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:Sanofi、AstraZeneca、CSL Ltd、Abbott、GlaxoSmithKline、Serum Institute of India
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...

Preventive vaccines are targeted at healthy populations and are available to susceptible populations.It refers to the preventive vaccination of the patient before the infection of the pathogen or in the body without the disease.In 2018, the global Preventive Vaccines market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Preventive Vaccines.

This study researches the market size of Preventive Vaccines, presents the global Preventive Vaccines sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Preventive Vaccines in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Preventive Vaccines for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
AstraZeneca
CSL Ltd
Abbott
GlaxoSmithKline
Serum Institute of India

Market Segment by Product Type
Intramuscular Injection
Nasal Spray
Intradermal Shot

Market Segment by Application
Hospital
Clinic
Other

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Preventive Vaccines status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Preventive Vaccines manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Preventive Vaccines are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Preventive Vaccines Market Size Growth Rate by Type
1.3.2 Intramuscular Injection
1.3.3 Nasal Spray
1.3.4 Intradermal Shot
1.4 Market Segment by Application
1.4.1 Global Preventive Vaccines Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Preventive Vaccines Market Size
2.1.1 Global Preventive Vaccines Revenue 2014-2025
2.1.2 Global Preventive Vaccines Sales 2014-2025
2.2 Preventive Vaccines Growth Rate by Regions
2.2.1 Global Preventive Vaccines Sales by Regions 2014-2019
2.2.2 Global Preventive Vaccines Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Preventive Vaccines Sales by Manufacturers
3.1.1 Preventive Vaccines Sales by Manufacturers 2014-2019
3.1.2 Preventive Vaccines Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Preventive Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Preventive Vaccines Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Preventive Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Preventive Vaccines Price by Manufacturers
3.4 Key Manufacturers Preventive Vaccines Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Preventive Vaccines Market
3.6 Key Manufacturers Preventive Vaccines Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Intramuscular Injection Sales and Revenue (2014-2019)
4.1.2 Nasal Spray Sales and Revenue (2014-2019)
4.1.3 Intradermal Shot Sales and Revenue (2014-2019)
4.2 Global Preventive Vaccines Sales Market Share by Type
4.3 Global Preventive Vaccines Revenue Market Share by Type
4.4 Preventive Vaccines Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Preventive Vaccines Sales by Application

6 North America
6.1 North America Preventive Vaccines Breakdown Data by Company
6.2 North America Preventive Vaccines Breakdown Data by Type
6.3 North America Preventive Vaccines Breakdown Data by Application
6.4 North America Preventive Vaccines Breakdown Data by Countries
6.4.1 North America Preventive Vaccines Sales by Countries
6.4.2 North America Preventive Vaccines Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Preventive Vaccines Breakdown Data by Company
7.2 Europe Preventive Vaccines Breakdown Data by Type
7.3 Europe Preventive Vaccines Breakdown Data by Application
7.4 Europe Preventive Vaccines Breakdown Data by Countries
7.4.1 Europe Preventive Vaccines Sales by Countries
7.4.2 Europe Preventive Vaccines Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Preventive Vaccines Breakdown Data by Company
8.2 Asia Pacific Preventive Vaccines Breakdown Data by Type
8.3 Asia Pacific Preventive Vaccines Breakdown Data by Application
8.4 Asia Pacific Preventive Vaccines Breakdown Data by Regions
8.4.1 Asia Pacific Preventive Vaccines Sales by Countries
8.4.2 Asia Pacific Preventive Vaccines Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Preventive Vaccines Breakdown Data by Company
9.2 Central & South America Preventive Vaccines Breakdown Data by Type
9.3 Central & South America Preventive Vaccines Breakdown Data by Application
9.4 Central & South America Preventive Vaccines Breakdown Data by Countries
9.4.1 Central & South America Preventive Vaccines Sales by Countries
9.4.2 Central & South America Preventive Vaccines Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Preventive Vaccines Breakdown Data by Type
10.2 Middle East and Africa Preventive Vaccines Breakdown Data by Application
10.3 Middle East and Africa Preventive Vaccines Breakdown Data by Countries
10.3.1 Middle East and Africa Preventive Vaccines Sales by Countries
10.3.2 Middle East and Africa Preventive Vaccines Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Preventive Vaccines
11.1.4 Preventive Vaccines Product Introduction
11.1.5 Sanofi Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Preventive Vaccines
11.2.4 Preventive Vaccines Product Introduction
11.2.5 AstraZeneca Recent Development
11.3 CSL Ltd
11.3.1 CSL Ltd Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Preventive Vaccines
11.3.4 Preventive Vaccines Product Introduction
11.3.5 CSL Ltd Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Preventive Vaccines
11.4.4 Preventive Vaccines Product Introduction
11.4.5 Abbott Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Preventive Vaccines
11.5.4 Preventive Vaccines Product Introduction
11.5.5 GlaxoSmithKline Recent Development
11.6 Serum Institute of India
11.6.1 Serum Institute of India Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Preventive Vaccines
11.6.4 Preventive Vaccines Product Introduction
11.6.5 Serum Institute of India Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Preventive Vaccines Sales Channels
12.2.2 Preventive Vaccines Distributors
12.3 Preventive Vaccines Customers

13 Market Forecast
13.1 Global Preventive Vaccines Sales and Revenue Forecast 2019-2025
13.2 Global Preventive Vaccines Sales Forecast by Type
13.3 Global Preventive Vaccines Sales Forecast by Application
13.4 Preventive Vaccines Forecast by Regions
13.4.1 Global Preventive Vaccines Sales Forecast by Regions 2019-2025
13.4.2 Global Preventive Vaccines Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Preventive Vaccines Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Preventive Vaccines Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Preventive Vaccines Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Preventive Vaccines Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Preventive Vaccines Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Preventive Vaccines Product Picture
Table Preventive Vaccines Key Market Segments
Table Major Manufacturers Preventive Vaccines Covered in This Report
Table Global Preventive Vaccines Market Size Growth Rate by Type 2019-2025 (K Doses) & (Million US$)
Figure Global Preventive Vaccines Sales Market Shar by Type 2014-2025
Figure Intramuscular Injection Figures
Table Major Manufacturers of Intramuscular Injection
Figure Nasal Spray Figures
Table Major Manufacturers of Nasal Spray
Figure Intradermal Shot Figures
Table Major Manufacturers of Intradermal Shot
Table Global Preventive Vaccines Market Share by Application 2019-2025 (K Doses)
Figure Hospital Use Case
Figure Clinic Use Case
Figure Other Use Case
Figure Preventive Vaccines Report Years Considered
Figure Global Preventive Vaccines Market Size 2014-2025 (Million US$)
Figure Global Preventive Vaccines Sales 2014-2019 (K Doses)
Table Global Preventive Vaccines Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global Preventive Vaccines Sales by Regions 2014-2019 (K Doses)
Table Global Preventive Vaccines Sales Market Share by Regions 2014-2019
Figure Global Preventive Vaccines Sales Market Share by Regions 2014-2019
Figure Global Preventive Vaccines Sales Market Share by Regions in 2018
Table Global Preventive Vaccines Revenue by Regions 2014-2019 (Million US$)
Table Global Preventive Vaccines Revenue Market Share by Regions 2014-2019
Figure Global Preventive Vaccines Revenue Market Share by Regions 2014-2019
Figure Global Preventive Vaccines Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Preventive Vaccines Sales by Manufacturers (2014-2019) (K Doses)
Table Global Preventive Vaccines Sales Share by Manufacturers (2014-2019)
Figure Global Preventive Vaccines Sales Share by Manufacturers in 2018
Table Preventive Vaccines Revenue by Manufacturers (2014-2019) (Million USD)
Table Preventive Vaccines Revenue Share by Manufacturers (2014-2019)
Figure Preventive Vaccines Value Share by Manufacturers in 2018
Table Global Preventive Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Preventive Vaccines Price (2014-2019) (USD/Doses)
Table Key Manufacturers Preventive Vaccines Plants/Factories Distribution
Table Key Manufacturers Preventive Vaccines Area Served
Table Date of Key Manufacturers Enter into Preventive Vaccines Market
Table Key Manufacturers Preventive Vaccines Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Intramuscular Injection Sales an目录输出!D Revenue (2014-2019) (K Doses) & (Million US$)
Table Global Nasal Spray Sales an目录输出!D Revenue (2014-2019) (K Doses) & (Million US$)
Table Global Intradermal Shot Sales an目录输出!D Revenue (2014-2019) (K Doses) & (Million US$)
Table Global Preventive Vaccines Sales by Type (2014-2019) (K Doses)
Table Global Preventive Vaccines Sales Share by Type (2014-2019)
Figure Global Preventive Vaccines Sales Market Share by Type (2014-2019)
Figure Global Preventive Vaccines Sales Market Share by Type in 2018
Table Global Preventive Vaccines Revenue by Type (2014-2019) (Million US$)
Table Global Preventive Vaccines Revenue Share by Type (2014-2019)
Figure Global Preventive Vaccines Revenue Market Share by Type (2014-2019)
Figure Global Preventive Vaccines Revenue Market Share by Type in 2018
Table Preventive Vaccines Price by Type 2014-2019 (USD/Doses)
Table Global Preventive Vaccines Sales by Application (2014-2019) (K Doses)
Table Global Preventive Vaccines Sales Share by Application (2014-2019)
Figure Global Sales Preventive Vaccines Market Share by Application (2014-2019)
Figure Global Sales Preventive Vaccines Market Share by Application in 2018
Figure North America Preventive Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure North America Preventive Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table North America Preventive Vaccines Sales by Company (2014-2019) (K Doses)
Table North America Preventive Vaccines Sales Market Share by Company (2014-2019)
Figure North America Preventive Vaccines Sales Market Share by Company in 2018
Table North America Preventive Vaccines Sales by Type (2014-2019) (K Doses)
Table North America Preventive Vaccines Sales Market Share by Type (2014-2019)
Figure North America Preventive Vaccines Market Share by Type in 2018
Table North America Preventive Vaccines Sales by Application (2014-2019) (K Doses)
Table North America Preventive Vaccines Sales Market Share by Application (2014-2019)
Figure North America Preventive Vaccines Market Share by Application in 2018
Table North America Preventive Vaccines Sales by Countries (2014-2019) (K Doses)
Table North America Preventive Vaccines Sales Market Share by Countries (2014-2019)
Figure North America Preventive Vaccines Sales Market Share by Countries in 2018
Table North America Preventive Vaccines Revenue by Countries (2014-2019) (Million US$)
Table North America Preventive Vaccines Revenue Market Share by Countries (2014-2019)
Figure North America Preventive Vaccines Revenue Market Share by Countries in 2018
Figure United States Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Canada Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Europe Preventive Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure Europe Preventive Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Preventive Vaccines Sales by Company (2014-2019) (K Doses)
Table Europe Preventive Vaccines Sales Market Share by Company (2014-2019)
Figure Europe Preventive Vaccines Sales Market Share by Company in 2018
Table Europe Preventive Vaccines Sales by Type (2014-2019) (K Doses)
Table Europe Preventive Vaccines Sales Market Share by Type (2014-2019)
Figure Europe Preventive Vaccines Sales Market Share by Type in 2018
Table Europe Preventive Vaccines Sales by Application (2014-2019) (K Doses)
Table Europe Preventive Vaccines Sales Market Share by Application (2014-2019)
Figure Europe Preventive Vaccines Sales Market Share by Application in 2018
Table Europe Preventive Vaccines Sales by Countries (2014-2019) (K Doses)
Table Europe Preventive Vaccines Sales Market Share by Countries (2014-2019)
Figure Europe Preventive Vaccines Sales Market Share by Countries in 2018
Table Europe Preventive Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Europe Preventive Vaccines Revenue Market Share by Countries (2014-2019)
Figure Europe Preventive Vaccines Revenue Market Share by Countries in 2018
Figure Germany Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure France Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure UK Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Italy Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Russia Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Asia Pacific Preventive Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific Preventive Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Preventive Vaccines Sales by Regions (2014-2019) (K Doses)
Table Asia Pacific Preventive Vaccines Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Preventive Vaccines Sales Market Share by Regions in 2018
Table Asia Pacific Preventive Vaccines Sales by Type (2014-2019) (K Doses)
Table Asia Pacific Preventive Vaccines Sales Market Share by Type (2014-2019)
Figure Asia Pacific Preventive Vaccines Market Share by Type in 2018
Table Asia Pacific Preventive Vaccines Sales by Application (2014-2019) (K Doses)
Table Asia Pacific Preventive Vaccines Sales Market Share by Application (2014-2019)
Figure Asia Pacific Preventive Vaccines Market Share by Application in 2018
Table Asia Pacific Preventive Vaccines Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific Preventive Vaccines Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Preventive Vaccines Sales Market Share by Regions in 2018
Table Asia Pacific Preventive Vaccines Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Preventive Vaccines Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Preventive Vaccines Revenue Market Share by Regions in 2018
Figure China Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure China Preventive Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Japan Preventive Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Korea Preventive Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure India Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure India Preventive Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Australia Preventive Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia Preventive Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia Preventive Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines Preventive Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand Preventive Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam Preventive Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Preventive Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America Preventive Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Preventive Vaccines Sales by Company (2014-2019) (K Doses)
Table Central & South America Preventive Vaccines Sales Market Share by Company (2014-2019)
Figure Central & South America Preventive Vaccines Sales Market Share by Company in 2018
Table Central & South America Preventive Vaccines Sales by Type (2014-2019) (K Doses)
Table Central & South America Preventive Vaccines Sales Market Share by Type (2014-2019)
Figure Central & South America Preventive Vaccines Market Share by Type in 2018
Table Central & South America Preventive Vaccines Sales by Application (2014-2019) (K Doses)
Table Central & South America Preventive Vaccines Sales Market Share by Application (2014-2019)
Figure Central & South America Preventive Vaccines Market Share by Application in 2018
Table Central & South America Preventive Vaccines Sales by Countries (2014-2019) (K Doses)
Table Central & South America Preventive Vaccines Sales Market Share by Countries (2014-2019)
Figure Central & South America Preventive Vaccines Sales Market Share by Countries in 2018
Table Central & South America Preventive Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Preventive Vaccines Revenue Market Share by Countries (2014-2019)
Figure Central & South America Preventive Vaccines Revenue Market Share by Countries in 2018
Figure Brazil Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil Preventive Vaccines Revenue Growth Rate (2014-2019) (K Doses)
Figure Middle East and Africa Preventive Vaccines Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa Preventive Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Preventive Vaccines Sales by Type (2014-2019) (K Doses)
Table Middle East and Africa Preventive Vaccines Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Preventive Vaccines Sales Market Share by Type in 2018
Table Middle East and Africa Preventive Vaccines Sales by Application (2014-2019) (K Doses)
Table Middle East and Africa Preventive Vaccines Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Preventive Vaccines Sales Market Share by Application in 2018
Table Middle East and Africa Preventive Vaccines Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa Preventive Vaccines Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Preventive Vaccines Sales Market Share by Countries in 2018
Table Middle East and Africa Preventive Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Preventive Vaccines Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Preventive Vaccines Revenue Market Share by Countries in 2018
Figure GCC Countries Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries Preventive Vaccines Revenue Growth Rate (2014-2019) (K Doses)
Figure Egypt Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt Preventive Vaccines Revenue Growth Rate (2014-2019) (K Doses)
Figure South Africa Preventive Vaccines Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa Preventive Vaccines Revenue Growth Rate (2014-2019) (K Doses)
Table Sanofi Company Details
Table Sanofi Description and Business Overview
Table Sanofi Preventive Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2014-2019)
Table Sanofi Preventive Vaccines Sales Growth Rate (2014-2019)
Table Sanofi Preventive Vaccines Sales Market Share in Global Market
Table Sanofi Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Description and Business Overview
Table AstraZeneca Preventive Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2014-2019)
Table AstraZeneca Preventive Vaccines Sales Growth Rate (2014-2019)
Table AstraZeneca Preventive Vaccines Sales Market Share in Global Market
Table AstraZeneca Recent Development
Table CSL Ltd Company Details
Table CSL Ltd Description and Business Overview
Table CSL Ltd Preventive Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2014-2019)
Table CSL Ltd Preventive Vaccines Sales Growth Rate (2014-2019)
Table CSL Ltd Preventive Vaccines Sales Market Share in Global Market
Table CSL Ltd Recent Development
Table Abbott Company Details
Table Abbott Description and Business Overview
Table Abbott Preventive Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2014-2019)
Table Abbott Preventive Vaccines Sales Growth Rate (2014-2019)
Table Abbott Preventive Vaccines Sales Market Share in Global Market
Table Abbott Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Preventive Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2014-2019)
Table GlaxoSmithKline Preventive Vaccines Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Preventive Vaccines Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table Serum Institute of India Company Details
Table Serum Institute of India Description and Business Overview
Table Serum Institute of India Preventive Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2014-2019)
Table Serum Institute of India Preventive Vaccines Sales Growth Rate (2014-2019)
Table Serum Institute of India Preventive Vaccines Sales Market Share in Global Market
Table Serum Institute of India Recent Development
Figure Preventive Vaccines Value Chain
Table Preventive Vaccines Distributors List
Table Preventive Vaccines Customers List
Table Global Preventive Vaccines Sales Forecast 2019-2025 (K Doses) & (Million US$)
Figure Global Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure Global Preventive Vaccines Revenue Forecast 2019-2025 (Million US$)
Table Global Preventive Vaccines Sales Forecast by Type 2019-2025 (K Doses)
Figure Global Preventive Vaccines Sales Forecast by Type 2019-2025 (K Doses)
Figure Global Preventive Vaccines Sales Market Share Forecast by Type 2019-2025
Table Global Preventive Vaccines Sales Forecast by Application 2019-2025 (K Doses)
Figure Global Preventive Vaccines Sales Forecast by Application 2019-2025 (K Doses)
Figure Global Preventive Vaccines Sales Market Share Forecast by Application 2019-2025
Table Global Preventive Vaccines Sales Forecast by Regions 2019-2025 (K Doses)
Figure Global Preventive Vaccines Sales Forecast by Regions 2019-2025 (K Doses)
Figure Global Preventive Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Global Preventive Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Preventive Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Preventive Vaccines Revenue Market Share Forecast by Regions 2019-2025
Table North America Preventive Vaccines Sales Forecast by Countries 2019-2025 (K Doses)
Table North America Preventive Vaccines Sales Market Share Forecast by Countries 2019-2025
Table North America Preventive Vaccines Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Preventive Vaccines Revenue Market Share Forecast by Countries 2019-2025
Figure United States Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure Canada Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure Mexico Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Table Europe Preventive Vaccines Sales Forecast by Countries 2019-2025 (K Doses)
Table Europe Preventive Vaccines Sales Market Share Forecast by Countries 2019-2025
Table Europe Preventive Vaccines Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Preventive Vaccines Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure France Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure UK Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure Italy Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure Russia Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Table Asia Pacific Preventive Vaccines Sales Forecast by Regions 2019-2025 (K Doses)
Table Asia Pacific Preventive Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Preventive Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Preventive Vaccines Revenue Market Share Forecast by Regions 2019-2025
Figure China Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure Japan Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure South Korea Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure India Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure Australia Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure Indonesia Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure Thailand Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure Malaysia Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure Philippines Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure Vietnam Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Table Central & South America Preventive Vaccines Sales Forecast by Countries 2019-2025 (K Doses)
Table Central & South America Preventive Vaccines Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Preventive Vaccines Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Preventive Vaccines Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Table Middle East and Africa Preventive Vaccines Sales Forecast by Regions 2019-2025 (K Doses)
Table Middle East and Africa Preventive Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Preventive Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Preventive Vaccines Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure GCC Countries Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure Egypt Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Figure South Africa Preventive Vaccines Sales Forecast 2019-2025 (K Doses)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources